Microbix Biosystems Inc (TSX:MBX)
C$ 0.345 -0.015 (-4.17%) Market Cap: 47.16 Mil Enterprise Value: 40.71 Mil PE Ratio: 9.09 PB Ratio: 1.69 GF Score: 66/100

Q2 2023 Microbix Biosystems Inc Earnings Presentation Transcript

May 16, 2023 / 03:00PM GMT
Release Date Price: C$0.42 (+12.00%)
Deborah Honig

Presentation
May 16, 2023 / 03:00PM GMT

=====================
Corporate Participants
=====================
* Cameron L. Groome
Microbix Biosystems Inc. - President, CEO & Director
* James S. Currie
Microbix Biosystems Inc. - CFO
* Kenneth Hughes
Microbix Biosystems Inc. - COO

=====================
Conference Call Participants
=====================
* Deborah Honig
* Magda Gardner

=====================
-

Cameron L. Groome
Microbix Biosystems Inc. - President, CEO & Director

Good morning, everyone, and thanks for joining us today. We have a very exciting update with Microbix as many of you know, they put out some very, very good news on Kinlytic this morning as well as they reported their fiscal Q2 results last week. With me today, I have Cameron Groome, Jim Currie and Ken Hughes, who I will change your name right now, Ken. Sorry about that.

-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot